D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 68 Citations 14,022 176 World Ranking 701 National Ranking 328

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Genetics

Shawn R. Lockhart spends much of his time researching Microbiology, Candida albicans, Fluconazole, Candida glabrata and Caspofungin. His Gene research extends to Microbiology, which is thematically connected. His study in Candida albicans is interdisciplinary in nature, drawing from both Phenotype, Mating type and Cell biology.

His biological study spans a wide range of topics, including Multiple drug resistance, Epidemiology and Candida auris. His Candida glabrata research incorporates themes from Antifungal drug and Incidence. The various areas that he examines in his Caspofungin study include Candida parapsilosis and Micafungin.

His most cited work include:

  • Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses (576 citations)
  • Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 (318 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)

What are the main themes of his work throughout his whole career to date?

Shawn R. Lockhart mostly deals with Microbiology, Candida auris, Cryptococcus gattii, Fluconazole and Genetics. Micafungin, Candida glabrata, Caspofungin, Anidulafungin and Echinocandin are among the areas of Microbiology where Shawn R. Lockhart concentrates his study. The concepts of his Candida auris study are interwoven with issues in Multiple drug resistance, Drug resistance, Outbreak and Infection control.

His Cryptococcus gattii study combines topics in areas such as Ecology and Virology. The Fluconazole study combines topics in areas such as Candida parapsilosis, Amphotericin B, Internal medicine, Epidemiology and Voriconazole. His research investigates the connection between Candida albicans and topics such as DNA profiling that intersect with issues in Southern blot.

He most often published in these fields:

  • Microbiology (44.58%)
  • Candida auris (17.92%)
  • Cryptococcus gattii (16.25%)

What were the highlights of his more recent work (between 2018-2021)?

  • Candida auris (17.92%)
  • Microbiology (44.58%)
  • Antifungal (10.83%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Candida auris, Microbiology, Antifungal, Outbreak and Intensive care medicine. The study incorporates disciplines such as Multiple drug resistance, Drug resistance, Yeast, Internal medicine and Fungus in addition to Candida auris. His is involved in several facets of Microbiology study, as is seen by his studies on Fluconazole, Broth microdilution, Amphotericin B, Echinocandins and Caspofungin.

His studies link Candida parapsilosis with Fluconazole. His Caspofungin research focuses on Echinocandin and how it relates to Micafungin, In vitro, Voriconazole and Itraconazole. His Outbreak research is multidisciplinary, incorporating elements of Epidemiology, Infection control, Whole genome sequencing, Transmission and Disease cluster.

Between 2018 and 2021, his most popular works were:

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • Candida auris and multidrug resistance: Defining the new normal. (48 citations)
  • On the Origins of a Species: What Might Explain the Rise of Candida auris? (42 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Genetics

His main research concerns Candida auris, Outbreak, Antifungal, Antifungal drug and Immune system. His study with Candida auris involves better knowledge in Microbiology. His Candida albicans and Micafungin investigations are all subjects of Microbiology research.

His work deals with themes such as Mortality rate, Infection control and Fungus, which intersect with Outbreak. In his work, Clinical microbiology is strongly intertwined with Broth dilution, which is a subfield of Antifungal drug. His Multiple drug resistance study integrates concerns from other disciplines, such as Amphotericin B, Fluconazole and Echinocandins.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses

Shawn R. Lockhart;Kizee A. Etienne;Snigdha Vallabhaneni;Joveria Farooqi.
Clinical Infectious Diseases (2017)

750 Citations

Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004

Shawn R. Lockhart;Murray A. Abramson;Susan E. Beekmann;Gale Gallagher.
Journal of Clinical Microbiology (2007)

542 Citations

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)

431 Citations

Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

M. A. Pfaller;M. Castanheira;S. R. Lockhart;A. M. Ahlquist.
Journal of Clinical Microbiology (2012)

384 Citations

Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008–2011

Angela Ahlquist Cleveland;Monica M. Farley;Lee H. Harrison;Betsy Stein.
Clinical Infectious Diseases (2012)

349 Citations

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

M.A. Pfaller;D.J. Diekema;D. Andes;M.C. Arendrup.
Drug Resistance Updates (2011)

335 Citations

Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011

Shawn R. Lockhart;Naureen Iqbal;Angela A. Cleveland;Monica M. Farley;Monica M. Farley.
Journal of Clinical Microbiology (2012)

274 Citations

Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Claude Pujol;Sophie Joly;Shawn R. Lockhart;Sebastien Noel.
Journal of Clinical Microbiology (1997)

270 Citations

Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosis

Shawn R. Lockhart;Shawn A. Messer;Michael A. Pfaller;Daniel J. Diekema.
Journal of Clinical Microbiology (2008)

260 Citations

Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016.

Snigdha Vallabhaneni;Alex Kallen;Sharon Tsay;Nancy Chow.
Morbidity and Mortality Weekly Report (2016)

256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shawn R. Lockhart

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 130

David S. Perlin

David S. Perlin

Rutgers, The State University of New Jersey

Publications: 89

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 89

David R. Soll

David R. Soll

Developmental Studies Hybridoma Bank

Publications: 89

Ferry Hagen

Ferry Hagen

Utrecht University

Publications: 85

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 82

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 82

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 81

Anuradha Chowdhary

Anuradha Chowdhary

University of Delhi

Publications: 80

Joseph Heitman

Joseph Heitman

Duke University

Publications: 76

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 68

Wieland Meyer

Wieland Meyer

University of Sydney

Publications: 64

Marie-Elisabeth Bougnoux

Marie-Elisabeth Bougnoux

Necker-Enfants Malades Hospital

Publications: 55

Arunaloke Chakrabarti

Arunaloke Chakrabarti

Post Graduate Institute of Medical Education and Research

Publications: 54

Neil A. R. Gow

Neil A. R. Gow

University of Exeter

Publications: 50

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 49

Something went wrong. Please try again later.